News | June 25, 2024
Arkema grants technology license to Seqens to manufacture PEKK for sale in medical implantable applications
PEKK is a high-performance polymer family used in aerospace and other demanding markets
PEKK is a high-performance polymer family used in aerospace and other demanding markets
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
Aurigene.AI is an end-to-end solution for small molecule drug discovery
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
With this, the total number of Patents granted to company for its innovative processes and technology stands at 9
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Subscribe To Our Newsletter & Stay Updated
